{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:55:30Z","timestamp":1782867330846,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","structuralheartjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structural Heart"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.shj.2025.100739","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:58:28Z","timestamp":1760551108000},"page":"100739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantification of Alpha-Gal Expression in Commercial BioProsthetic Heart Valves and Its Potential Mitigation"],"prefix":"10.1016","volume":"10","author":[{"given":"Andrea","family":"Colli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Maria","family":"Calafiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Padalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-8799","authenticated-orcid":false,"given":"Filippo","family":"Naso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.shj.2025.100739_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1159\/000533633","article-title":"Patterns of aortic valve replacement in Europe: adoption by age","volume":"148","author":"Rudolph","year":"2023","journal-title":"Cardiology"},{"key":"10.1016\/j.shj.2025.100739_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.21470\/1678-9741-2020-0635","article-title":"Bioprosthetic aortic valve degeneration: a review from a basic science perspective","volume":"37","author":"Velho","year":"2022","journal-title":"Braz J Cardiovasc Surg"},{"key":"10.1016\/j.shj.2025.100739_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2362.2005.01441.x","article-title":"Alpha-gal on bioprostheses: xenograft immune response in cardiac surgery","volume":"35","author":"Konakci","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.shj.2025.100739_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1185395","article-title":"Alpha-gal specific IgG immune response after implantation of bioprostheses","volume":"57","author":"Mangold","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.shj.2025.100739_bib5","first-page":"222","article-title":"Anti-alpha-Gal antibody response following xenogeneic heart valve implantation in adults","volume":"22","author":"Park","year":"2013","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.shj.2025.100739_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41591-022-01682-w","article-title":"The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration","volume":"28","author":"Senage","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.shj.2025.100739_bib7","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/iai.56.7.1730-1737.1988","article-title":"Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora","volume":"56","author":"Galili","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.shj.2025.100739_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezac227","article-title":"Alpha-gal-specific humoral immune response and reported clinical consequences for cardiac valve replacement in patients below 65 years: moving beyond conjecture","volume":"62","author":"Copic","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.shj.2025.100739_bib9","doi-asserted-by":"crossref","first-page":"ezac115","DOI":"10.1093\/ejcts\/ezac115","article-title":"Immunoreaction to xenogenic tissue in cardiac surgery: alpha-gal and beyond","volume":"62","author":"Calafiore","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.shj.2025.100739_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jocs.12764","article-title":"Premature bioprosthetic aortic valve degeneration associated with allergy to Galactose-Alpha-1,3-Galactose","volume":"31","author":"Hawkins","year":"2016","journal-title":"J Card Surg"},{"key":"10.1016\/j.shj.2025.100739_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/xen.12288","article-title":"Antibody formation towards porcine tissue in patients implanted with crosslinked heart valves is directed to antigenic tissue proteins and \u03b1-Gal epitopes and is reduced in healthy vegetarian subjects","volume":"24","author":"B\u00f6er","year":"2017","journal-title":"Xenotransplant"},{"key":"10.1016\/j.shj.2025.100739_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1210098","article-title":"Correlations between the alpha-gal antigen, antibody response, and calcification of cardiac valve bioprostheses: experimental evidence obtained using an alpha-gal knockout mouse animal model","volume":"14","author":"Naso","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.shj.2025.100739_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31083\/j.fbl2905181","article-title":"The \u03b1-Gal KO mouse animal model is a reliable and predictive tool for the immune-mediated calcification assessment of heart valve bioprostheses","volume":"29","author":"Naso","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.shj.2025.100739_bib14","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.healun.2009.10.007","article-title":"Gal knockout pig pericardium: new source of material for heart valve bioprostheses","volume":"29","author":"Lila","year":"2010","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.shj.2025.100739_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10719-020-09931-1","article-title":"Identification by mass spectrometry and immunoblotting of xenogeneic antigens in the N- and O-Glycomes of porcine, bovine, and equine heart tissues","volume":"37","author":"Jin","year":"2020","journal-title":"Glycoconj J"},{"key":"10.1016\/j.shj.2025.100739_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/xen.12044","article-title":"First quantification of alpha-gal epitope in current glutaraldehyde-fixed heart valve bioprostheses","volume":"20","author":"Naso","year":"2013","journal-title":"Xenotransplant"},{"key":"10.1016\/j.shj.2025.100739_bib17","article-title":"Method for inactivating xenoantigens in biological tissues","author":"Naso","year":"2022","journal-title":"Eur Patent"},{"key":"10.1016\/j.shj.2025.100739_bib18","article-title":"Method for preventing the formation of calcified deposits and for inactivating xenoantigens in biological matrices","author":"Naso","year":"2019","journal-title":"Eur Patent"},{"key":"10.1016\/j.shj.2025.100739_bib19","article-title":"A method for the preparation of surfaces, particularly of cardiac prosthesis","author":"Naso","year":"2021","journal-title":"Eur Patent"},{"key":"10.1016\/j.shj.2025.100739_bib20","first-page":"190","article-title":"Detoxification process for glutaralde-hyde-treated bovine pericardium: biological, chemical, and mechanical characterization","volume":"7","author":"Y Stacchino","year":"1998","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.shj.2025.100739_bib21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1089\/ten.tea.2016.0474","article-title":"Alpha-gal-inactivated heart valve bioprostheses exhibit an anti-calcification propensity similar to knockout tissues","volume":"23","author":"Naso","year":"2017","journal-title":"Tissue Eng A"},{"key":"10.1016\/j.shj.2025.100739_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1161\/CIRCULATIONAHA.105.549311","article-title":"Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection","volume":"114","author":"Manji","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.shj.2025.100739_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.909801","article-title":"Mechanisms and drug therapies of bioprosthetic heart valve calcification","volume":"13","author":"Wen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"Suppl_1","key":"10.1016\/j.shj.2025.100739_bib24","article-title":"Polyphenol-treatment without preceding glutaraldehyde fixation: a potential paradigm change for bioprosthetic heart valves","volume":"45","author":"Melica","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.shj.2025.100739_bib25","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1016\/0003-4975(95)00291-R","article-title":"Relevance of immunologic reactions for tissue failure of bioprosthetic heart valves","volume":"60","author":"Dahm","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.shj.2025.100739_bib26","doi-asserted-by":"crossref","first-page":"S385","DOI":"10.1016\/S0003-4975(01)02492-4","article-title":"Characterization of the immune response to valve bioprostheses and its role in primary tissue failure","volume":"71","author":"Human","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.shj.2025.100739_bib27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0022-5223(20)31465-3","article-title":"Immunogenicity of glutaraldehyde-tanned bovine pericardium","volume":"99","author":"Dahm","year":"1990","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.shj.2025.100739_bib28","first-page":"520","article-title":"Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation","volume":"12","author":"Wilhelmi","year":"2003","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.shj.2025.100739_bib29","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.actbio.2010.11.030","article-title":"First quantitative assay of alpha-gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves","volume":"7","author":"Naso","year":"2011","journal-title":"Acta Biomater"},{"key":"10.1016\/j.shj.2025.100739_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.15585\/mmwr.mm7230a2","article-title":"Geographic distribution of suspected alpha-gal syndrome cases\u2014united states, January 2017\u2013December 2022","volume":"72","author":"Thompson","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.shj.2025.100739_bib31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ejcts\/ezv070","article-title":"The TRIBECA study: (tri)fecta (b)ioprosthesis (e)valuation versus (c)arpentier magna-ease in (a)ortic position","volume":"49","author":"Colli","year":"2016","journal-title":"Eur J Cardiothora Surg"},{"key":"10.1016\/j.shj.2025.100739_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11748-022-01904-5","article-title":"Externally mounted versus internally mounted leaflet aortic bovine pericardial bioprosthesis: meta-analysis","volume":"71","author":"Yokoyama","year":"2023","journal-title":"Gen Thorac Cardiovas Surg"},{"key":"10.1016\/j.shj.2025.100739_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/icvts\/ivz277","article-title":"An in vitro comparison of internally versus externally mounted leaflets in surgical aortic bioprostheses","volume":"30","author":"Vriesendorp","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.shj.2025.100739_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.26502\/fccm.92920287","article-title":"Polyphenols could be effective in exerting a disinfectant-like action on bioprosthetic heart valves, counteracting bacterial adhesiveness","volume":"6","author":"Naso","year":"2022","journal-title":"Cardiol Cardiovasc Med"},{"key":"10.1016\/j.shj.2025.100739_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezac583","article-title":"Preventing extrinsic mechanisms of bioprosthetic degeneration using polyphenols","volume":"63","author":"Melder","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.shj.2025.100739_bib36","first-page":"5239","article-title":"Safety of green tea catechins","volume":"16","year":"2018","journal-title":"EFSA J"},{"issue":"1","key":"10.1016\/j.shj.2025.100739_bib37","first-page":"53","article-title":"Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate (EGCG)","volume":"10","author":"Chow","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.shj.2025.100739_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.fct.2005.11.002","article-title":"Safety studies on epigallocatechin gallate (EGCG) preparations","volume":"44","author":"Isbrucker","year":"2006","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.shj.2025.100739_bib39","article-title":"Test No. 401: Acute Oral Toxicity","year":"1987","journal-title":"OECD Guidel Test Chemicals"},{"issue":"5","key":"10.1016\/j.shj.2025.100739_bib40","first-page":"602","article-title":"Dose-dependent levels of epigallocatechin-3-gallate in human plasma and its effect on biomarkers of oxidative stress","volume":"51","author":"Lambert","year":"2007","journal-title":"Mol Nutr Food Res"},{"issue":"8","key":"10.1016\/j.shj.2025.100739_bib41","first-page":"2349","article-title":"Safety of quercetin: a review of clinical studies in humans","volume":"57","author":"Andres","year":"2018","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.shj.2025.100739_bib42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","article-title":"Polyphenols: food sources and bioavailability","volume":"79","author":"Manach","year":"2004","journal-title":"Am J Clin Nutr"}],"container-title":["Structural Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2474870625003318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2474870625003318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:43:34Z","timestamp":1773420214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2474870625003318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2474870625003318"],"URL":"https:\/\/doi.org\/10.1016\/j.shj.2025.100739","relation":{},"ISSN":["2474-8706"],"issn-type":[{"value":"2474-8706","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of Alpha-Gal Expression in Commercial BioProsthetic Heart Valves and Its Potential Mitigation","name":"articletitle","label":"Article Title"},{"value":"Structural Heart","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.shj.2025.100739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Cardiovascular Research Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100739"}}